This page is in Beta testing. We welcome your feedback and suggestions as we look to improve this page.
Latest news
Stay informed on our major announcements through our media releases and other updates.
-
-
-
News articles
Read our latest news on regulatory decisions and activities, including product safety and enforcement actions. -
-
Safety updates
Refer to our articles for health professionals about health products and emerging safety issues. -
Health product safety alerts and market actions
See the latest alerts for consumers and health professionals about safety and quality issues with health products.
-
Safety alerts
Refer to the latest safety alerts for medicines or medical devices with possible risks. -
Events and consultations
Have your say on therapeutic goods regulation by participating in our public consultations or browse closed consultations. We also deliver a range of webinars, workshops and meetings on areas of interest for industry, consumers, and health professionals.
-
Consultations
Search open and closed consultations on the way we regulate medicines, medical devices and biologicals. -
Events
Search our upcoming and past events including webinars, committee meetings, presentations, and workshops.
Our subscription services
Stay connected and sign up to our RSS news feeds and email subscription services to receive real-time updates on our latest news, product shortage alerts, and media releases as we publish them, or subscribe to monthly updates.
-
Email subscriptions
We offer several email subscription options to keep you up to date with news and alerts. -
RSS feeds
RSS feeds (Really Simple Syndication feed) for immediate notifications of updates to the TGA website.
Industry notices and compliance undertakings
Notifications for sponsors, manufacturers, and advertisers about official decisions and new or updated regulatory requirements, as well as information about recent regulatory compliance and enforcement actions.
-
Regulatory decision notices
Access official regulatory decisions for sponsors, manufacturers and advertisers, including GMP clearances, listing notices, administrative instruments, and updates to regulatory requirements. -
Latest articles
-
Court orders CDA Clinics QLD and its former director to pay $6.95 million for unlawful advertising of medicinal cannabis
Media releasesThe Federal Court of Australia has ordered CDA Clinics QLD Pty Ltd (CDA Clinics) to pay $6.5 million in civil penalties for the unlawful advertising of medicinal cannabis to the public. -
Crackdown in Queensland targeting illegal tobacco, vapes and nicotine products
Media releasesWe conducted a coordinated enforcement operation in Coopers Plains and Acacia Ridge together with Queensland Health and the Queensland Police Service. The operation targeted the alleged unlawful storage and distribution of illicit vaping goods, illicit tobacco and unapproved nicotine products. -
TGA statement on Consumer NZ sunscreen testing
Media releasesWe are aware of recent sunscreen testing undertaken by Consumer NZ, which reported Sun Protection Factor (SPF) results for a number of sunscreens.
Latest publications
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement 57
-
Meeting statementsAdvisory Committee on Biologicals meeting statement
Latest consultations
-
ConsultationWe're seeking feedback on proposed changes to the requirements of ingredients used in listed (low-risk) medicines. Myristica fragrans use during pregnancy and lactation and requirements relating to amygdalin and hydrocyanic acid.
-
ConsultationThe Therapeutic Goods Administration (TGA) is seeking public comment on proposed changes to the Therapeutic Goods (Permissible Ingredients) Determination relating to listed medicines containing vitamin B6, namely pyridoxine hydrochloride, pyridoxal 5-phosphate and pyridoxal 5-phosphate monohydrate.
-
ConsultationHave your say about the content and level of detection for ethylene oxide, propylene oxide and epichlorohydrin in end use products.